Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer
Cancer Gene Therapy, Published online: 07 November 2023; doi:10.1038/s41417-023-00683-2Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Xuan Li Yuan Zhang Tengjiang Zhang Luyang Zhao Christopher G. Lin Haitian Hu Hanqiu Zheng Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Haiti Health | Tamoxifen